BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37169445)

  • 21. Lessons from genomic profiling: towards a molecular-based classification of ovarian Sertoli-Leydig cell tumour.
    Kommoss FKF
    Histopathology; 2024 Mar; 84(4):712-714. PubMed ID: 38114269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FOXL2 Mutation Analysis of Ovarian Sex Cord-Stromal Tumors: Genotype-Phenotype Correlation With Diagnostic Considerations.
    Buza N; Wong S; Hui P
    Int J Gynecol Pathol; 2018 Jul; 37(4):305-315. PubMed ID: 28700438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Application of molecular analysis in differential diagnosis of ovarian adult granulosa cell tumors].
    Zheng XZ; Ma JH; Chen TB; Xu F; Zou ZY; Zhang LH; Jin YL; Zhan Y
    Zhonghua Bing Li Xue Za Zhi; 2020 Aug; 49(8):794-799. PubMed ID: 32746545
    [No Abstract]   [Full Text] [Related]  

  • 24. DICER1 Mutation in Recurrent Ovarian Sertoli-Leydig Cell Tumor: A Case Report.
    Liu S; Pokoradi AJ; Soboleski D; Childs T; Agrawal A
    J Pediatr Adolesc Gynecol; 2023 Apr; 36(2):107-111. PubMed ID: 36402443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An immunohistochemical and molecular analysis of problematic and unclassified ovarian sex cord-stromal tumors.
    Stewart CJ; Alexiadis M; Crook ML; Fuller PJ
    Hum Pathol; 2013 Dec; 44(12):2774-81. PubMed ID: 24134930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Moderately differentiated Sertoli-Leydig cell tumour: a hormone-secreting neoplasm associated with DICER1 syndrome.
    Khan S; Hodgson A
    Int J Gynecol Cancer; 2023 Dec; 33(12):1981-1982. PubMed ID: 37543372
    [No Abstract]   [Full Text] [Related]  

  • 27. Case report: an identical twin with Sertoli-Leydig cell tumor.
    Cho K; Havelock JC; Gilks B; Dunne C
    Gynecol Endocrinol; 2018 Jul; 34(7):563-566. PubMed ID: 29366348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DICER1 and FOXL2 Mutation Status Correlates With Clinicopathologic Features in Ovarian Sertoli-Leydig Cell Tumors.
    Karnezis AN; Wang Y; Keul J; Tessier-Cloutier B; Magrill J; Kommoss S; Senz J; Yang W; Proctor L; Schmidt D; Clement PB; Gilks CB; Huntsman DG; Kommoss F
    Am J Surg Pathol; 2019 May; 43(5):628-638. PubMed ID: 30986800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutational analysis (c.402C>G) of the FOXL2 gene and immunohistochemical expression of the FOXL2 protein in testicular adult type granulosa cell tumors and incompletely differentiated sex cord stromal tumors.
    Hes O; Vaněček T; Petersson F; Grossmann P; Hora M; Perez Montiel DM; Steiner P; Dvořák M; Michal M
    Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):347-51. PubMed ID: 21293260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Ovarian Sertoli-Leydig cell tumors: DICER1 hotspot mutations and associated clinicopathological features].
    Xiao YX; Zhu XL; Bi R; Tu XY; Cheng YF; Chang B; Yu L; Huang D; Lu YM; Shan L; Yang WT
    Zhonghua Bing Li Xue Za Zhi; 2020 May; 49(5):441-447. PubMed ID: 32392927
    [No Abstract]   [Full Text] [Related]  

  • 31. Mixed sex cord-stromal tumor (gynandroblastoma) with malignant morphology involving both ovaries: a case report.
    Maraqa B; Al-Ashhab M; Kamal N; Sughayer M; Barakat F
    J Int Med Res; 2023 Jul; 51(7):3000605231187796. PubMed ID: 37493465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sertoli-Leydig cell tumor: a clinicopathological analysis in a comprehensive, national cohort.
    Bekker P; Miland-Samuelsen AR; Smerdel MP; Schnack TH; Lauszus FF; Karstensen SH
    Int J Gynecol Cancer; 2023 Dec; 33(12):1921-1927. PubMed ID: 37907261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 14-3-3 sigma is a useful immunohistochemical marker for diagnosing ovarian granulosa cell tumors and steroid cell tumors.
    Chen L; Yang B
    Int J Gynecol Pathol; 2013 Mar; 32(2):156-62. PubMed ID: 23370648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Practical Review of Ovarian Sex Cord-Stromal Tumors.
    Hanley KZ; Mosunjac MB
    Surg Pathol Clin; 2019 Jun; 12(2):587-620. PubMed ID: 31097116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The pathology of hereditary ovarian tumors].
    Pesce F; Devouassoux-Shisheboran M
    Ann Pathol; 2020 Apr; 40(2):85-94. PubMed ID: 32178889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD56 is a sensitive and diagnostically useful immunohistochemical marker of ovarian sex cord-stromal tumors.
    McCluggage WG; McKenna M; McBride HA
    Int J Gynecol Pathol; 2007 Jul; 26(3):322-7. PubMed ID: 17581419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ovarian sex cord-stromal tumours and their mimics.
    Young RH
    Pathology; 2018 Jan; 50(1):5-15. PubMed ID: 29132723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The oncogenic roles of DICER1 RNase IIIb domain mutations in ovarian Sertoli-Leydig cell tumors.
    Wang Y; Chen J; Yang W; Mo F; Senz J; Yap D; Anglesio MS; Gilks B; Morin GB; Huntsman DG
    Neoplasia; 2015 Aug; 17(8):650-60. PubMed ID: 26408257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rare DICER1 and Absent FOXL2 Mutations Characterize Ovarian Juvenile Granulosa Cell Tumors.
    Baillard P; Genestie C; Croce S; Descotes F; Rouleau E; Treilleux I; Gouy S; Morice P; Ray-Coquard I; McCluggage WG; Devouassoux-Shisheboran M
    Am J Surg Pathol; 2021 Feb; 45(2):223-229. PubMed ID: 32910017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gynandroblastoma With Juvenile Granulosa Cell Tumor and Concurrent Renal Cell Carcinoma: A Case Report and Review of Literature.
    Wilberger A; Yang B
    Int J Surg Pathol; 2015 Aug; 23(5):393-8. PubMed ID: 26169919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.